Comparison of Long-Term Outcome in Anthracycline-Related Versus Idiopathic Dilated Cardiomyopathy: A Single Centre Experience

Abstract

Cardiovascular mortality in patients with AICM did not differ from that of a matched IDCM cohort, despite cancer-related morbidity and less prevalent use of devices. These data suggest that patients with AICM should be treated with appropriate guideline-directed medical therapies similar to other non-ischaemic dilated cardiomyopathies.